What does a modified-Fibonacci dose-escalation actually correspond to?
<p>Abstract</p> <p>Background</p> <p>In most phase I oncology trials, it is often stated that the dose increments follow a “modified-Fibonacci sequence”. This term, however, is vague.</p> <p>Methods</p> <p>To better characterize this sequence, we...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-07-01
|
| Series: | BMC Medical Research Methodology |
| Subjects: | |
| Online Access: | http://www.biomedcentral.com/1471-2288/12/103 |